Galvin Gaustad & Stein’s GE HealthCare GEHC Stock Holding History

Galvin Gaustad & Stein’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10M	Sell	156,388 -25,709	-14%	-$1.69M	0.74%	49
2026 Q1	$13M	Sell	182,097 -7,737	-4%	-$610K	1.04%	37
2025 Q4	$15.6M	Buy	189,834 +3,645	+2%	+$284K	1.22%	31
2025 Q3	$14M	Buy	186,189 +8,260	+5%	+$616K	1.14%	41
2025 Q2	$13.2M	Buy	177,929 +12,141	+7%	+$845K	1.14%	38
2025 Q1	$13.4M	Buy	165,788 +9,665	+6%	+$831K	1.2%	39
2024 Q4	$12.2M	Sell	156,123 -77,944	-33%	-$6.63M	1.09%	40
2024 Q3	$22M	Buy	234,067 +2,266	+1%	+$190K	1.96%	16
2024 Q2	$18.1M	Buy	231,801 +7,790	+3%	+$635K	1.68%	24
2024 Q1	$20.4M	Sell	224,011 -69,219	-24%	-$5.76M	1.87%	23
2023 Q4	$22.7M	Buy	293,230 +12,342	+4%	+$864K	2.12%	13
2023 Q3	$19.1M	Buy	+280,888	New	+$20.4M	1.94%	17

Other funds holding GEHC

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Galvin Gaustad & Stein's GEHC Position: Q2 2026 in Review

Galvin Gaustad & Stein reduced its GE HealthCare (GEHC) stake by 14% in Q2 2026, selling an estimated $1.69M and leaving 156,388 shares worth $10M. The position accounts for 0.74% of the portfolio, ranked #49.

Galvin Gaustad & Stein first reported a position in GEHC in Q3 2023 and has held it in 12 quarters since. The position peaked at $22.7M in Q4 2023. 1,226 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

Galvin Gaustad & Stein held 156,388 shares of GE HealthCare worth $10M as of Q2 2026.
Galvin Gaustad & Stein sold 25,709 GE HealthCare shares in Q2 2026, an estimated $1.69M.
GE HealthCare made up 0.74% of Galvin Gaustad & Stein's portfolio in Q2 2026, its #49 holding.
Galvin Gaustad & Stein first reported a position in GE HealthCare in Q3 2023 and has held it in 12 quarters since.
Galvin Gaustad & Stein's GE HealthCare position peaked at $22.7M in Q4 2023.
1,226 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Galvin Gaustad & Stein's 13F filing for Q2 2026, filed 29 Jul 2026.